BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System

  March 17, 2025

   · 

  8 min read
• Press Releases

  FILAMENT HEALTH ANNOUNCES POSITIVE DATA FROM PHASE 2 STUDY OF PEX010 IN PATIENTS WITH ALCOHOL USE DISORDER

  March 17, 2025

   · 

  5 min read
• Press Releases

  ZORYVE® Cream 0.15% Approved by Health Canada for the Treatment of Mild to Moderate Atopic Dermatitis in Adults and Children as Young as Six Years of Age

  March 17, 2025

   · 

  10 min read
• Press Releases

  Precision BioSciences Announces Clearance of Investigational New Drug Application by the U.S. FDA for First-in-Class PBGENE-HBV Designed to Eliminate Root Cause of Chronic Hepatitis B

  March 17, 2025

   · 

  12 min read
• Press Releases

  MindMed Appoints Matt Wiley as Chief Commercial Officer

  March 17, 2025

   · 

  7 min read
• Press Releases

  Enanta Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

  March 17, 2025

   · 

  1 min read
• Press Releases

  Bausch + Lomb Launches Arise™ Orthokeratology Lens System in the United States

  March 17, 2025

   · 

  6 min read
• Press Releases

  Orca Bio Announces Positive Results from the Pivotal Phase 3 Study of Investigational Orca-T® Compared to Allogeneic Stem Cell Transplant for the Treatment of Hematologic Malignancies

  March 17, 2025

   · 

  6 min read
• Press Releases

  Aptose Biosciences Meets Nasdaq Minimum Bid Price Compliance

  March 17, 2025

   · 

  3 min read
• Press Releases

  Mineralys Therapeutics Announces Data from the Phase 2 Advance-HTN Trial of Lorundrosat for the Treatment of Hypertension Has Been Accepted as a Late-Breaking Presentation at the 2025 American College of Cardiology’s Annual Scientific Session & Expo

  March 17, 2025

   · 

  5 min read